Morgan E. Yashchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Morgan E. Yashchenko has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bibi Maryam
Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, 73104, USA
2 shared publications - Kurt A. Zimmerman
Division of Nephrology, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
2 shared publications - Sarah J. Miller
Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, 73104, USA
2 shared publications - Alex Yashchenko
Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, 73104, USA
1 shared publication - Audrey M. Cordova
Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, 73104, USA
1 shared publication - Fariha Nusrat
Department of Internal Medicine, Division of Nephrology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, 73104, USA
1 shared publication
Latest Publications
- Open Access
- 7 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 1956-1967
The Kinetics and Mechanism of Niche Filling in Healthy and Cystic Mice
Key Points: The rate and mechanism of kidney-resident macrophage niche filling differs between healthy and cystic mice. An incompletely filled kidney-resident macrophage niche is associated with worsened polycystic kidney disease outcomes. Background: Previous data indicate that bone marrow–derived Ly6c hi monocytes can become tissue-resident macrophages when the niche is available. However, the balance between monocyte recruitment and tissue-resident macrophage self-proliferation following partial depletion is unclear. Methods: We investigated the kinetics and mechanism of kidney-resident macrophage (KRM) niche filling in healthy mice and in a mouse model of autosomal dominant polycystic kidney disease after partial depletion with liposomal clodronate. Results: Our data indicate that healthy mice efficiently refilled their KRM niche through monocyte-dependent recruitment, engraftment, and differentiation while cystic mice relied preferentially on in situ KRM self-proliferation for niche filling. Furthermore, we found sex-specific differences in niche-filling capacity in cystic mice as female, but not male, mice were unable to completely fill their niche 90 days postdepletion. The inability of cystic female mice to fill the niche following depletion was likely due to their reduced ability to recruit monocytes and convert them into KRM. Phenotypically, delayed KRM niche filling was associated with worsened outcomes including increased cystic index and kidney fibrosis as well as worsened kidney function. Conclusions: Collectively, our data demonstrate that sex and disease status affect the kinetics and mechanism of niche filling in the kidney.
- 7 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 1956-1967
Open AccessThe Kinetics and Mechanism of Niche Filling in Healthy and Cystic Mice
Key Points: The rate and mechanism of kidney-resident macrophage niche filling differs between healthy and cystic mice. An incompletely filled kidney-resident macrophage niche is associated with worsened polycystic kidney disease outcomes. Background: Previous data indicate that bone marrow–derived Ly6c hi monocytes can become tissue-resident macrophages when the niche is available. However, the balance between monocyte recruitment and tissue-resident macrophage self-proliferation following partial depletion is unclear. Methods: We investigated the kinetics and mechanism of kidney-resident macrophage (KRM) niche filling in healthy mice and in a mouse model of autosomal dominant polycystic kidney disease after partial depletion with liposomal clodronate. Results: Our data indicate that healthy mice efficiently refilled their KRM niche through monocyte-dependent recruitment, engraftment, and differentiation while cystic mice relied preferentially on in situ KRM self-proliferation for niche filling. Furthermore, we found sex-specific differences in niche-filling capacity in cystic mice as female, but not male, mice were unable to completely fill their niche 90 days postdepletion. The inability of cystic female mice to fill the niche following depletion was likely due to their reduced ability to recruit monocytes and convert them into KRM. Phenotypically, delayed KRM niche filling was associated with worsened outcomes including increased cystic index and kidney fibrosis as well as worsened kidney function. Conclusions: Collectively, our data demonstrate that sex and disease status affect the kinetics and mechanism of niche filling in the kidney.
- Open Access
- 1 February 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (3) , 459-470
Macrophage Ontogeny, Phenotype, and Function in Ischemia Reperfusion-Induced Injury and Repair
AKI is characterized by a sudden, and usually reversible, decline in kidney function. In mice, ischemia–reperfusion injury (IRI) is commonly used to model the pathophysiologic features of clinical AKI. Macrophages are a unifying feature of IRI as they regulate both the initial injury response as well as the long-term outcome following resolution of injury. Initially, macrophages in the kidney take on a proinflammatory phenotype characterized by the production of inflammatory cytokines, such as CCL2 (monocyte chemoattractant protein 1), IL-6, IL-1β, and TNF-α. Release of these proinflammatory cytokines leads to tissue damage. After resolution of the initial injury, macrophages take on a reparative role, aiding in tissue repair and restoration of kidney function. By contrast, failure to resolve the initial injury results in prolonged inflammatory macrophage accumulation and increased kidney damage, fibrosis, and the eventual development of CKD. Despite the extensive amount of literature that has ascribed these functions to M1/M2 macrophages, a recent paradigm shift in the macrophage field now defines macrophages on the basis of their ontological origin, namely monocyte-derived and tissue-resident macrophages. In this review, we focus on macrophage phenotype and function during IRI-induced injury, repair, and transition to CKD using both the classic (M1/M2) and novel (ontological origin) definition of kidney macrophages.
- 1 February 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (3) , 459-470
Open AccessMacrophage Ontogeny, Phenotype, and Function in Ischemia Reperfusion-Induced Injury and Repair
AKI is characterized by a sudden, and usually reversible, decline in kidney function. In mice, ischemia–reperfusion injury (IRI) is commonly used to model the pathophysiologic features of clinical AKI. Macrophages are a unifying feature of IRI as they regulate both the initial injury response as well as the long-term outcome following resolution of injury. Initially, macrophages in the kidney take on a proinflammatory phenotype characterized by the production of inflammatory cytokines, such as CCL2 (monocyte chemoattractant protein 1), IL-6, IL-1β, and TNF-α. Release of these proinflammatory cytokines leads to tissue damage. After resolution of the initial injury, macrophages take on a reparative role, aiding in tissue repair and restoration of kidney function. By contrast, failure to resolve the initial injury results in prolonged inflammatory macrophage accumulation and increased kidney damage, fibrosis, and the eventual development of CKD. Despite the extensive amount of literature that has ascribed these functions to M1/M2 macrophages, a recent paradigm shift in the macrophage field now defines macrophages on the basis of their ontological origin, namely monocyte-derived and tissue-resident macrophages. In this review, we focus on macrophage phenotype and function during IRI-induced injury, repair, and transition to CKD using both the classic (M1/M2) and novel (ontological origin) definition of kidney macrophages.